Female 58.9%, male 41.1%; disease duration over 10 years accounted for the highest rate of 44%, with an associated complication 63.1%, Family history of diabetes was 55.1%; activity of monotherapy drug treatment is 25.8%, combined oral and injection is 29.4%; payment according to health insurance rate is 51.9%, periodical management of postprandial blood glucose test is fully implemented at 95.3%, HbA1c is fully implemented periodically at 49.5%; Periodic re-examination is 81.8%.